Why Clinician-Led AI Strategies Are Gaining Momentum in Healthcare
The future of healthcare AI may depend less on algorithms and more on credibility. Presbyterian Healthcare Services is testing that theory with a clinician-led deployment strategy.
Read More
Should you adopt a new treatment if the only evidence comes from other countries?
If you are a payer or a policymaker, should you except the results of a global clinical trial or require additional evidence that a drug works in your country. There are a few options to consider. Delay approval until local confirmatory trial. Approach enacted in several Asian countries (see Habr et al. 2024). While this…
Hospital Prices Have Risen Much Faster for Private Insurance Than Medicare Since 2019
This brief compares the prices paid by private insurers for hospital care to increases in Medicare payment using data from the Bureau of Labor Statistics (BLS) Producer Price Index (PPI), finding that hospital prices have risen much faster for private insurance than Medicare since 2019.
Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology
Organizations that can generate and apply high-quality, clinically grounded evidence will be better positioned to close the gap between what is proven in trials and what is achieved in practice. The post Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology appeared first on MedCity News.
What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape
The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined. The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.
Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them
Cost management strategies need to focus on simplifying the system, doing away with the outdated processes that inflate costs, and building and deploying tools that allow organizations to control their spending. The post Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them appeared first on MedCity News.
A Look at the High Unemployment Hardship Exception to Medicaid Work Requirements Based on Unemployment Data from February 2025 to January 2026
In the 39 states that are adopting or may adopt the high unemployment hardship exception, about 1.4 million or 7.5% of Medicaid expansion enrollees live in one of the 133 counties that currently meet the high-unemployment criteria.
Kids Keep Getting Stuck in Hospitals, Even After Being Cleared for Discharge
Overwhelmed by the demands of caregiving, Quette dialed 911 when she found her teenage son downstairs in their kitchen struggling to breathe. He had rolled his wheelchair to the oven to keep himself warm as he tried to regulate his temperature, she recalled, and was drenched in sweat from an apparent infection. In that moment,…
A Danish Couple’s Maverick African Research Finds Its Moment in RFK Jr.’s Vaccine Policy
In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe. Her supervisor, a fellow Dane named Peter Aaby, had spent nearly two decades collecting data on 100,000 people living in the mud brick homes of the West African country’s capital. Aaby and his partner, Christine Stabell Benn, believed that the…
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s…